Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Wuchter

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Experimental Hematology|March 30, 2006
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomesWolfgang Wagner, Robert E Feldmann, Anja Seckinger, et al.
International Journal of Molecular Sciences|July 27, 2022
Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell CarcinomaAlexander Rühle, Marie Lies, Maren Strack, et al.
Molecular Systems Biology|January 27, 2017
Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferationLorenz Adlung, Sandip Kar, Marie-Christine Wagner, et al.
Frontiers in Immunology|May 14, 2023
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assaysAlina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, et al.
Plos One|October 1, 2019
Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAsSusanne Delecluse, Jiyang Yu, Katharina Bernhardt, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
Transfusion|September 12, 2025
SARS-CoV-2 convalescent plasma for the controlled clinical trial "COVIC-19": Experience from collection of very high-titer plasma from superimmunized individualsSimone Hoffmann, Alina Seidel, Carolin Ludwig, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Haematologica|May 28, 2017
Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemiaWenwen Wang, Thomas Stiehl, Simon Raffel, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Experimental Hematology|March 30, 2006
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomesWolfgang Wagner, Robert E Feldmann, Anja Seckinger, et al.
International Journal of Molecular Sciences|July 27, 2022
Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell CarcinomaAlexander Rühle, Marie Lies, Maren Strack, et al.
Molecular Systems Biology|January 27, 2017
Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferationLorenz Adlung, Sandip Kar, Marie-Christine Wagner, et al.
Frontiers in Immunology|May 14, 2023
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assaysAlina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, et al.
Plos One|October 1, 2019
Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAsSusanne Delecluse, Jiyang Yu, Katharina Bernhardt, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
Transfusion|September 12, 2025
SARS-CoV-2 convalescent plasma for the controlled clinical trial "COVIC-19": Experience from collection of very high-titer plasma from superimmunized individualsSimone Hoffmann, Alina Seidel, Carolin Ludwig, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Haematologica|May 28, 2017
Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemiaWenwen Wang, Thomas Stiehl, Simon Raffel, et al.
Pageof 12